tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market

ArriVent BioPharma, Inc. (AVBP) Income Statement

15 Followers

ArriVent BioPharma, Inc. Income Statement

Last quarter (Q ), ArriVent BioPharma, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q, ArriVent BioPharma, Inc.'s net income was $―. See ArriVent BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
$ 36.91M
Operating Income
$ -36.91M
Net Non Operating Interest Income Expense
-
Other Income Expense
-
Pretax Income
$ -36.91M
Tax Provision
-
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -36.91M
Basic EPS
$ -0.03
Diluted EPS
$ -0.03
Basic Average Shares
$ 1.28B
Diluted Average Shares
$ 1.28B
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 36.91M
Net Income From Continuing And Discontinued Operation
$ -36.91M
Normalized Income
-
Interest Expense
-
EBIT
-
EBITDA
-
Currency in USD

ArriVent BioPharma, Inc. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis